Palliation of liver metastases with combined hepatic irradiation and misonidazole. Results of a Radiation Therapy Oncology Group Phase I-II study.
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008111:Liver Function Tests; D008113:Liver Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D008920:Misonidazole / Q000627:therapeutic use*; D009593:Nitroimidazoles / Q000627:therapeutic use*; D009929:Organ Size; D010166:Palliative Care; D013997:Time Factors
D009593:Nitroimidazoles; D008920:Misonidazole; D000469:Alkaline Phosphatase